We report a rare artiJaet observed during eleetronystagmography (ENG) in a 54-year-oldwoman. Rhythmie waves were seen on ENG even though no eorresponding movements ofthe eyes or eyelids were deteeted, even by infrared camera monitoring. The rhythmie waves eorresponded to the patient's pulse and oeeurred after the appearanee of eaeh QRS eomplex on electrocardiography (ECG). The waves were believed to have been generated by the pulse ofthe artery near the electrodes, wh ich represented eontamination ofplethysmography at the temple. To the best ofour knowledge, such an artifact has not been previously reported in the literature. When rhythmic waves unrelated to eye movements are reeorded du ring ENG. an artiJaet of eardiovaseular origin should be nt/ed out, and ECG and direet observation ofthe eyes are necessary .
Introduction
Electronystagmography (ENG) enables otolaryngologists to make a quantitative assessment of eye movements and deteet both peripheral and central vestibular disorders.' :? ENG measures comeoretinal potentials, so any kind of electrical "noise"-such as electrocardiography (ECG), myography, or electroencephalography-may cause artifacts .
In this article, we report a rare ENG artifact that corresponded with the patient's pulse. To the best of our knowledge, such an artifact has not been previously reported in the literature.
Case report
A 54-year-old woman with hereditary spinocerebellar degeneration was referred to our department for a neurootologic assessment. She was very thin. No abnormalities were found on blood biochemistry testingo No spontaneous nystagmus was found, but gaze nystagmus was observed during left and right gaze. ENG was performed. Horizontal electrodes were placed bitemporally, and vertical electrodes were placed above and below the right eye . Saccadic eye movement, dysmetria, and lateral gaz e nystagmus were observed. During this examination, rhythmic waves were recorded by the horizontal ENG leads , but no such wave was recorded by the verticalleads (figure I). The waves were wide and left-beating, and the waveform changed during the examination (figure 2). No corresponding eye movements or blinks were seen during observation with Frenzel's goggles orwith infrared camera monitoring. The rhythmic waves were synchronous with the radial and carotid pulses. Simultaneous electrocardiography (ECG) revealed that the waves occurred just after the appearance of the QRS complex ( figure 3 ).
We concluded that these abnormai waves represented artifact that corresponded to the arterial pulse on the patient's face.
Discussion
In this case , no eye movements were observed during infrared camera monitoring, so the abnormai waves were believed to be artifact. The abnormal waves corresponded to the patient's pulse and occurred after the appearance of the QRS complex. The QRS complex rarely appears on ENG .3Only the T wave was believed to be a candidate for this abnormai wave from the viewpointoftiming. However, the abnormai waves changed form during the examination, even though the positions ofthe electrodes were fixed to the skin . T waves may change form in patients with hypo-or hyperkalemia, but ourpatienthad no electrolyte imbalance. Moreover, the rhythmic waves themselves were not similar to the T waves or the QRS complex waves.
The rhythmic waves in this case might have represented the arterial pulse at the temple-that is, the ENG may have functioned as impedance plethysmography of the artery. Impedance plethysmography is a method ofdetecting blood volume changes, in part by measuring changes in electrical resistance." Although the electrodes on our patient were fixed tightly to her skin, the position of the vesseI beneath the skin might have changed slightly and the form of the wave might have changed during ENG.
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ECG.
Another interestin g aspect ofthis case is that the artifact resembled a left-beating nystagmus on ENG.The inereased resistanee eaused by the blood volume lowered the voltage, whieh might have appe ared on ENG as a downward (i.e., left) shift.
We reeommend that when rhythm ie waves unrelated to eye movements are reeorded during ENG , artifaet of eardiov aseular origin should be ruled out, and ECG and direet observation of the eyes should be perfonned. 
